Description
Please note: This workshop will be recorded.
As the number of states legalizing medical cannabis increases, so does the need for an educated workforce to respond to the demand for medical cannabis with an understanding and expertise regarding the science and therapeutic effects of this medicinal plant. Traditional educational programs for health care practitioners, analytical chemists, agriculturists, policy makers, business and sales professionals have not typically included instruction on the science, policy, and therapeutics of medical cannabis. Specifically, health care professionals report significant gaps in their cannabis-related knowledge, which this program aims to start to rectify. This session by Drs. Buckley and Johnson will provide an introduction to the field of medical cannabis science and therapeutics, and will be accessible to all.
***Please be advised: This training will be recorded for marketing purposes.***
Instructor
Dr. Leah Sera, Program Director, Master of Science in Medical Cannabis Science and Therapeutics, University of Maryland School of Pharmacy
Dr. Sera is an Associate Professor of Pharmacy Practice and Program Director for the Master of Science in Medical Cannabis Science and Therapeutics (MCST) program at the University of Maryland School of Pharmacy. Dr. Sera received her PharmD from the University of Maryland School of Pharmacy and completed two years of post-graduate training, specializing in palliative care. She is a board-certified pharmacotherapy specialist and completed a Master of Arts in Instructional Systems Development at the University of Maryland Baltimore County.
Dr. Johnson is an Instructor in the Department of Pharmaceutical Sciences and Co-Director of the Medical Cannabis Science and Therapeutics (MCST) program at the University of Maryland School of Pharmacy. Dr. Johnson received his PhD in Pharmaceutical Sciences (focus: Medicinal Chemistry and Pharmacology) from the University of Maryland, Baltimore School of Pharmacy in 2019. His research focuses on two primary areas: the design and synthesis of novel, fast-acting antidepressants targeting the muscarinic receptors (mAChRs) and novel opioid analgesics with reduced tolerance, dependence, and reinforcement.
Agenda & Learning Objectives
AGENDA:
| 9:30 |
Registration |
| 10:00 |
Lecture: |
| 11:30 |
Break |
| 11:45 |
Lecture (Continued) |
| 12:15 |
Questions & Adjournment |
LEARNING OBJECTIVES:
Upon the completion of this workshop, participants will be able to:
- List the components of cannabis and describe their mechanisms of action
- Critically analyze the evidence for and against the benefits of medical cannabis for treating a range of conditions
Bibliography & References
BIBLIOGRAPHY & REFERENCES
References:
- 1.Gaoni, Y., Mechoulam, R.J., 1964. Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86, 1646-1647.
- 2.Mechoulam, R.J., 1973. Marijuana: chemistry, pharmacology and clinical effects. New York: Academic Press; pg. 2-99.
- 3.Martin, B.R., Mechoulam, R.J., Razdan, R.K., 1999. Discovery and characterization of endogenous cannabinoids. Life Sci. 65(6-7), 573-595.
Late Fees and Refunds
Fee & Registration:
Cost is $70 and includes CE credit. Registering after September 23, 2022 will incur an additional $20 late fee. *Cancellations must be received 24 hours in advance prior to the live interactive webinar to receive a refund or a credit letter.
*All cancellations will be subjected to a $35.00 administration fee
Target Audience
Social Workers, LCPCs, and Psychologists
All those interested in Topic Welcomed
